The AIRFoundry facility — funded by a six-year, $18 million National Science Foundation grant — brings together researchers ...

For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for their condition. Exome sequencing came back clean. Chromosomal microarray found ...

The RNA world hypothesis posits that molecules made up of ribonucleic acids (RNA) are responsible for kickstarting evolution ...

Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new layer of genetic regulation that could reshape how certain cancers are ...

Canadians swallow millions of pills every day to treat common health issues like high blood pressure, high cholesterol and ...

Quarterly RNA drug plozasiran turns off a liver gene, sharply lowering life‑threatening pancreatitis attacks in a rare ...

Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...

Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors, ...

Key market opportunities in the RNA extraction and purification sector include the growing demand for RNA-based therapies and diagnostics, the development of user-friendly and automated kits, and the ...

The recent success of mRNA vaccines has heightened interest in RNA-based therapy, which significantly expands the scope of druggable targets. Currently, small interfering RNAs and antisense ...

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.